Proto-Oncogene Proteins c-akt, antagonists & inhibitors
DBCAT003064Pharmacologic class
A DrugBank category of 2 drugs. 1 of them is approved.
What you can answer from here — as of February 08, 2017
Which targets do Proto-Oncogene Proteins c-akt, antagonists & inhibitors share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account